Utility of adjunctive single oral bolus propafenone therapy in patients with atrial defibrillators

Europace

Volumn 8, Issue 3, 2006, Pages 211-215

  Schwartzman, David ^a   Harvey, Mark N ^b   Hoyt, Robert H ^c   Koehler, Jodi L ^d   Ujhelyi, Michael R ^d   Euler, David E ^d  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b Oklahoma Foundation for Cardiovascular Research   (United States)

^c IOWA HEART CENTER   (United States)

^d MEDTRONIC INC   (United States)

Author keywords

Antiarrhythmic drug; Atrial defibrillator; Atrial fibrillation; Implantable cardioverter defibrillator; Pacing

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DOFETILIDE; PLACEBO; PROPAFENONE; SOTALOL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DEFIBRILLATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART PACING; HEART PROARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SINUS RHYTHM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; DEFIBRILLATOR; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PROPAFENONE;

EID: 33646843927     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euj051     Document Type: Article

References (19)

1. Fuster V, Rydén LE, Asinger RW et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001;22:1852-1923.
2. Schoels W, Swerdlow CD, Jung W et al. Worldwide clinical experience with a new dual-chamber implantable cardioverter-defibrillator system. J Cardiovasc Electrophys 2001;12:521-8.
3. Adler SW II, Wolpert C, Warman EN, Musley SK, Koehler JL, Euler DE. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 2001;104:887-92.
4. Friedman PA, Dijkman B, Warman EN et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001; 104:1023-8.
5. Gold MR, Sulke N, Schwartzman DS, Mehra R, Euler DE. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001; 12:1247-53.
6. Swerdlow CD, Schwartzman D, Hoyt R, Bailin SJ, Koehler JL, Warman EN. Determinants of first-shock success for atrial implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2002;13:347-54.
7. Schwartzman D, Musley SK, Swerdlow CD, Hoyt RH, Warman EN. Early recurrence of atrial fibrillation following ambulatory shock conversion. J Am Coll Cardiol 2002;40:93-9.
8. Capucci A, Boriani G, Botto GL et al. Conversion of recent-onset atrial fibrillation by single oral loading dose of propafenone or flecainide. Am J Cardiol 1994;74:503-5.
9. Capucci A, Boriani G, Rubino I, Della Casa S, Sanguinetti M, Magnani B. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol 1994;43:305-13.
10. Boriani G, Capucci A, Lenzi T, Sanguinetti M, Magnani B. Propafenone for conversion of recent-onset atrial fibrillation: A controlled comparison between oral loading dose and intravenous administration. Chest 1995; 108:355-8.
11. Botto GL, Bonini W, Broffoni T et al. Conversion of recent-onset atrial fibrillation with single loading oral dose of propafenone: Is in-hospital admission absolutely necessary. Pacing Clin Electrophysiol 1996;19: 1939-43.
12. Azpitarte J, Alvarez M, Baun O et al. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. Eur Heart J 1997;18: 1649-54.
13. Boriani G, Biffi M, Capucci A et al. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. Ann Intern Med 1997;126:621-5.
14. Botto GL, Capucci A, Bonini W et al. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: Comparison of two regimens. Int J Cardiol 1997;58:55-61.
15. Khan IA. Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. J Am Coll Cardiol 2001;37:542-7.
16. Capucci A, Villani GQ, Piepoli MF. Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation. Am J Cardiol 2003;92:1345-7.
17. Alboni P, Botto GL, Baldi N et al. Outpatient treatment of recent-onset atrial fibrillation with the 'pill-in-the-pocket' approach. N Engl J Med 2004;351:2384-91.
18. Ujhelyi MR, O'Rangers EA, Fan C, Kluger J, Pharand C, Chow MSS. The pharmacokinetic and pharmacodynamic interaction between propafenone and lidocaine. Clin Pharmacol Ther 1993;53:38-48.
19. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: A generalized estimating equation approach. Biometrics 1988;44:1049-60.